Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -26.12% is 57% above its 5-year average of -61.05%, near the high end of its 5-year range (-88.48%–-22.89%).
22.71% above its 12-month average of -33.80%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -4.66%.
RETURN ON ASSETS (ROA)
-26.12%
RETURN ON ASSETS (ROA) AVG TTM
-33.80%
RETURN ON ASSETS (ROA) AVG 3Y
-51.84%
RETURN ON ASSETS (ROA) AVG 5Y
-61.05%
RETURN ON ASSETS (ROA) AVG 10Y
-43.85%
RETURN ON ASSETS (ROA) AVG 15Y
-56.55%
RETURN ON ASSETS (ROA) AVG 20Y
-62.66%
CURRENT VS TTM AVG
+22.71%
CURRENT VS 3Y AVG
+49.62%
CURRENT VS 5Y AVG
+57.22%
CURRENT VS 10Y AVG
+40.43%
CURRENT VS 15Y AVG
+53.81%
CURRENT VS 20Y AVG
+58.31%
SECTOR MEDIAN · HEALTHCARE
-31.80%
median of 830 covered companies
CURRENT VS SECTOR MEDIAN
+17.86%
vs the sector median at left
Madrigal Pharmaceuticals, Inc.
Market Cap
$11.46B
Return on Assets (ROA)
-26.12%
TTM Avg
-33.80%
3Y Avg
-51.84%
5Y Avg
-61.05%
Market Cap
$11.34B
Return on Assets (ROA)
7.03%
TTM Avg
4.83%
3Y Avg
6.67%
5Y Avg
7.46%
Market Cap
$10.94B
Return on Assets (ROA)
4.50%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
Market Cap
$10.82B
Return on Assets (ROA)
0.62%
TTM Avg
5.35%
3Y Avg
3.84%
5Y Avg
4.82%
Market Cap
$10.85B
Return on Assets (ROA)
-20.33%
TTM Avg
-23.04%
3Y Avg
-23.77%
5Y Avg
-25.30%
Market Cap
$10.63B
Return on Assets (ROA)
9.58%
TTM Avg
8.61%
3Y Avg
6.84%
5Y Avg
6.99%
Market Cap
$12.35B
Return on Assets (ROA)
8.33%
TTM Avg
7.48%
3Y Avg
6.38%
5Y Avg
5.99%
Market Cap
$12.42B
Return on Assets (ROA)
2.01%
TTM Avg
3.05%
3Y Avg
3.16%
5Y Avg
3.84%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | $11.46B | -26.12% | -33.80% | -51.84% | -61.05% |
| Bio-Techne Corporation (TECH)vs › | $11.34B | 7.03% | 4.83% | 6.67% | 7.46% |
| DaVita Inc. (DVA)vs › | $11.61B | 4.79% | 4.84% | 4.27% | 4.56% |
| The Cooper Companies, Inc. (COO)vs › | $10.94B | 4.50% | 3.10% | 3.02% | 7.71% |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.82B | 0.62% | 5.35% | 3.84% | 4.82% |
| Twist Bioscience Corporation (TWST)vs › | $10.85B | -20.33% | -23.04% | -23.77% | -25.30% |
| Universal Health Services, Inc. (UHS)vs › | $10.63B | 9.58% | 8.61% | 6.84% | 6.99% |
| Encompass Health Corporation (EHC)vs › | $12.35B | 8.33% | 7.48% | 6.38% | 5.99% |
| ICON Public Limited Company (ICLR)vs › | $12.42B | 2.01% | 3.05% | 3.16% | 3.84% |
| BrightSpring Health Services, Inc. Common Stock (BTSG)vs › | $12.47B | 4.91% | 1.34% | -0.28% | 0.04% |
ROA
-26.1%
ROE
-62.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -22.89% |
| 2024-12-31 | -44.70% |
| 2023-12-31 | -58.33% |
| 2022-12-31 | -81.46% |
| 2021-12-31 | -88.48% |
| 2020-12-31 | -70.47% |
| 2019-12-31 | -18.99% |
| 2018-12-31 | -6.76% |
| 2017-12-31 | -16.20% |
| 2016-12-31 | -64.03% |
| 2015-12-31 | -10.04% |
| 2014-12-31 | -85.58% |
| 2013-12-31 | -94.74% |
| 2012-12-31 | -60.95% |
| 2011-12-31 | -111.95% |
| 2010-12-31 | -69.30% |
| 2009-12-31 | 161.70% |
| 2008-12-31 | -95.23% |
| 2007-12-31 | -51.77% |
| 2006-12-31 | -104.53% |
| 2005-12-31 | -96.70% |
| 2004-12-31 | -34.79% |
| 2003-12-31 | -34.68% |
| 2002-12-31 | 0.00% |
| 2001-12-31 | -13.74% |
